Oncolytics Biotech (ONCY) Receivables (2009 - 2017)
Oncolytics Biotech's Receivables was $62,109 in Q3 2017, up 38.0% from $44,991 a year earlier but down 29.2% from the prior quarter.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Receivables (2009 - 2017) Analysis & Trends
At the end of FY2016, Receivables at Oncolytics Biotech came in at $95,496, down 71.9% from FY2015.
- Receivables shows a five-year compound annual growth rate of 11.5% (FY2011 to FY2016).
- In earlier years, Receivables was $340,059 in FY2015 (+77.3%), $191,751 in FY2014 (+81.1%), $105,853 in FY2013 (+135.3%) and $44,979 in FY2012 (-18.8%).
- Quarterly Receivables has moved between $35,402 (Q3 2013) and $340,059 (Q4 2015) over five years.
- Compared with a year earlier, Receivables was higher in four of the last eight quarters, with growth averaging 8.7%.
- The best year-over-year quarter for Receivables over five years was Q3 2014 (growth of 139.7%); the worst was Q4 2016 (a decline of 72.0%).
- Per Business Quant data, ONCY's Receivables in the three quarters before Q3 2017 was $87,734 (Q2 2017), $36,484 (Q1 2017) and $95,194 (Q4 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Oncolytics Biotech | 60.94 Mn | 32.05 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 62,109.00 |
| Jun 30, 2017 | 87,734.00 |
| Mar 31, 2017 | 36,484.00 |
| Dec 31, 2016 | 94,772.22 |
| Sep 30, 2016 | 44,991.00 |
| Jun 30, 2016 | 285,426.00 |
| Mar 31, 2016 | 59,648.00 |
| Dec 31, 2015 | 340,059.00 |
| Sep 30, 2015 | 53,040.00 |
| Jun 30, 2015 | 61,261.00 |
| Mar 31, 2015 | 45,706.00 |
| Dec 31, 2014 | 191,751.00 |
| Sep 30, 2014 | 84,865.00 |
| Jun 30, 2014 | 54,391.00 |
| Mar 31, 2014 | 43,507.00 |
| Dec 31, 2013 | 105,853.00 |
| Sep 30, 2013 | 35,402.00 |
| Jun 30, 2013 | 31,236.00 |
| Mar 31, 2013 | 77,976.00 |
| Dec 31, 2012 | 44,979.00 |
API Access
Oncolytics Biotech Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();